1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-arginine vasopressin has been researched along with Shock, Traumatic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gong, A; Lin, BC; Sun, K; Wang, CH; Zhu, HN | 1 |
1 other study(ies) available for 1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)-2-(o-ethyl-tyr)-4-val-arginine vasopressin and Shock, Traumatic
| Article | Year |
|---|---|
Effect of peripheral injection of arginine vasopressin and its receptor antagonist on burn shock in the rat.
Topics: Angiotensin Receptor Antagonists; Animals; Arginine Vasopressin; Burns; Electrocardiography; Heart Rate; Histocytochemistry; Injections, Intravenous; Male; Myocardial Contraction; Rats; Rats, Inbred Strains; Receptors, Vasopressin; Shock, Traumatic | 1990 |